A cross-sectional analysis shows that long-acting antiretroviral therapy sustains viral suppression regardless of initial ...

In this Healio Video Perspective from the ARVO meeting, Justis P. Ehlers, MD, shares results from the phase 1 HELIOS study investigating OTX-TKI for the treatment of nonproliferative diabetic ...

With its twice-yearly dosing, the siRNA-based drug might lead to better compliance with treatment. Still, cost is an issue.

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

Earlier PT initiation and more frequent sessions are associated with a reduced risk for future IAT use among individuals with knee OA.